{"id":449816,"date":"2025-12-13T13:35:00","date_gmt":"2025-12-13T12:35:00","guid":{"rendered":"https:\/\/medizinonline.com\/new-recommendations-on-cvd-risk-classification-lipid-lowering-in-statin-intolerance-and-hofh\/"},"modified":"2025-12-12T23:05:55","modified_gmt":"2025-12-12T22:05:55","slug":"new-recommendations-on-cvd-risk-classification-lipid-lowering-in-statin-intolerance-and-hofh","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/en\/new-recommendations-on-cvd-risk-classification-lipid-lowering-in-statin-intolerance-and-hofh\/","title":{"rendered":"New recommendations on CVD risk classification, lipid lowering in statin intolerance and hoFH"},"content":{"rendered":"\n<p><strong>The <em>European Society of Cardiology<\/em> (ESC) and <em>European Atherosclerosis Society <\/em>(EAS) guideline update on the management of dyslipidemia continues to focus largely on how best to manage lipid levels to reduce cardiovascular (CV) risk. Although some things have remained the same, some important new recommendations have been added, based on evidence from several clinical trials published from 2019 onwards. <\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/en\/my-account\/packages\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/en\/log-in\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fen%2Fnew-recommendations-on-cvd-risk-classification-lipid-lowering-in-statin-intolerance-and-hofh%2F\">Log in here<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>The European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) guideline update on the management of dyslipidemia continues to focus largely on how best to manage lipid levels to&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/en\/my-account\/packages\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/en\/log-in\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fen%2Fnew-recommendations-on-cvd-risk-classification-lipid-lowering-in-statin-intolerance-and-hofh%2F\">Log in here<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":449818,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Lipid management: ESC\/EAS guideline update 2025","footnotes":""},"category":[11359,11513,11384,11548,11503],"tags":[72426,86965,11816,86967,18247,15901,69319],"powerkit_post_featured":[],"class_list":["post-449816","post","type-post","status-publish","format-standard","has-post-thumbnail","category-cardiology","category-congress-reports","category-endocrinology-and-diabetology","category-rx-en","category-studies","tag-cvd-en","tag-cvd-risk-classification","tag-dyslipidemia-en","tag-esc-eas-guideline-update-2025","tag-lipid-lowering","tag-lipid-management-en","tag-statin-intolerance","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-05-02 06:40:06","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":449813,"slug":"nouvelles-recommandations-sur-la-classification-du-risque-de-mcv-la-reduction-des-lipides-en-cas-dintolerance-aux-statines-et-lhofh","post_title":"Nouvelles recommandations sur la classification du risque de MCV, la r\u00e9duction des lipides en cas d'intol\u00e9rance aux statines et l'hoFH","href":"https:\/\/medizinonline.com\/fr\/nouvelles-recommandations-sur-la-classification-du-risque-de-mcv-la-reduction-des-lipides-en-cas-dintolerance-aux-statines-et-lhofh\/"},"it_IT":{"locale":"it_IT","id":449807,"slug":"nuove-raccomandazioni-sulla-classificazione-del-rischio-cvd-sullabbassamento-dei-lipidi-nellintolleranza-alle-statine-e-sullhofh","post_title":"Nuove raccomandazioni sulla classificazione del rischio CVD, sull'abbassamento dei lipidi nell'intolleranza alle statine e sull'hoFH","href":"https:\/\/medizinonline.com\/it\/nuove-raccomandazioni-sulla-classificazione-del-rischio-cvd-sullabbassamento-dei-lipidi-nellintolleranza-alle-statine-e-sullhofh\/"},"pt_PT":{"locale":"pt_PT","id":449802,"slug":"novas-recomendacoes-sobre-classificacao-do-risco-de-dcv-reducao-dos-lipidos-em-caso-de-intolerancia-as-estatinas-e-hofh","post_title":"Novas recomenda\u00e7\u00f5es sobre classifica\u00e7\u00e3o do risco de DCV, redu\u00e7\u00e3o dos l\u00edpidos em caso de intoler\u00e2ncia \u00e0s estatinas e hoFH","href":"https:\/\/medizinonline.com\/pt-pt\/novas-recomendacoes-sobre-classificacao-do-risco-de-dcv-reducao-dos-lipidos-em-caso-de-intolerancia-as-estatinas-e-hofh\/"},"es_ES":{"locale":"es_ES","id":449799,"slug":"nuevas-recomendaciones-sobre-la-clasificacion-del-riesgo-de-ecv-la-reduccion-de-lipidos-en-caso-de-intolerancia-a-las-estatinas-y-la-hofh","post_title":"Nuevas recomendaciones sobre la clasificaci\u00f3n del riesgo de ECV, la reducci\u00f3n de l\u00edpidos en caso de intolerancia a las estatinas y la hoFH","href":"https:\/\/medizinonline.com\/es\/nuevas-recomendaciones-sobre-la-clasificacion-del-riesgo-de-ecv-la-reduccion-de-lipidos-en-caso-de-intolerancia-a-las-estatinas-y-la-hofh\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/449816","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/comments?post=449816"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/449816\/revisions"}],"predecessor-version":[{"id":449819,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/449816\/revisions\/449819"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/media\/449818"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/media?parent=449816"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/category?post=449816"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/tags?post=449816"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/powerkit_post_featured?post=449816"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}